With a proven track record in oncology, the organization is now expanding its expertise into the dermatology sector. Building on its success in in-house API manufacturing, the team aims to bring the same level of innovation and quality to the derma space. By leveraging backward integration and strong R&D capabilities, they are poised to introduce a range of new treatments that address unmet needs in both oncology and dermatology. This strategic diversification highlights their commitment to broadening their therapeutic portfolio while maintaining leadership in key areas of healthcare.
About the company
Beta Drugs Ltd (Mcap 1247 Cr, when first posted on prudentparrot.com), currently Mcap 1644 Cr is a 30+ years old company engaged in manufacturing a wide range of branded generic oncology (anti-cancer) drugs in India.
About the Management
Rahul Batra is the Chairman and Managing Director of the Company. He holds a Master of Science degree in Business and Management from the University of Strathclyde Scotland. His Scope of work includes managing the Marketing and Sales segment of the Company.
Varun Batra is the Joint Managing Director of the Company. He holds a Degree in Business Management from Toronto Canada. His Scope of work includes monitoring the Production Department and Export sales of the Company.
Balwant Singh is the Director of the Company. He holds a degree in PGDPM-HR & IR from DAV College of Management, Chandigarh. He holds 19 years of experience in the field of pharmaceuticals. His scope of work includes managing all affairs of the Company.
Ashutosh Shukla is a director of sales & marketing responsible for handling domestic and international markets. He holds an executive MBA degree from Symbiosis International University, Pune. He has more than 20 years of experience in sales & marketing in top pharmaceutical companies.
Sanjeev Chopra is a Vice President-Technical. He has more than 22 years of Industrial Experience in Quality Operations (QA/QC) in Pharmaceutical & Biopharmaceutical formulations. He holds a degree MSC in Microbiology from Gurukula Kangi University, Haridwar.
Nipun Arora is the Chief Financial Officer (CFO) of the Company. He is a Chartered Accountant and a member of the Institute of Chartered Accountants of India. He is also admitted as a member of the Institute of Company Secretaries of India and the Institute of Cost & Works Accountants of India. He has experience in the fields of Financial Management, Accounts and Auditing, Taxation and Statutory Compliance.
Business Verticals
To read the full article, please subscribe to PRUDENT Ideas Membership!
See you next time.
Until then… Stay Prudent!
Disclaimer: This article is provided for informational purposes only and should not be considered as an investment advice
Also read:
thanks for the detailed note. What’s your view on the current valuation.